Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice
Fields of Study & Subjects
Alzheimer's disease research and treatments
Neuroinflammation and Neurodegeneration Mechanisms
Glycosylation and Glycoproteins Research
Publication details
- Journal / source
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Volume
- 392
- Pages
- 114710–114710
- Publication date
- 15 February 2026
- Language
- EN